Cerulean

Novartis links up with Cerulean in NDC deal
BioPharma Dive
Thu, 10/20/16 - 09:28 am
Novartis
Cerulean
NDCs
drug development
R&D
Cerulean pitches $75M IPO to give its cancer drug another shot
Fierce Biotech
Tue, 03/11/14 - 08:45 am
IPOs
Cerulean
CRLX101
FierceBiotech's 2011 Fierce 15 Biotech Companies
Fierce Biotech
Wed, 09/7/11 - 11:28 am
Blueprint Medicines
Cerulean
Cerenis Therapeutics
Epizyme
Forma Therapeutics
Intrexon
Merrimack Pharmaceuticals
f-star
Pfenex
Pearl Therapeutics
Reata
Selecta
Rib-X Pharmaceuticals
Tesaro
Theraclone
Lilly Ventures leads $24M round for Cerulean's PhII
Fierce Biotech
Mon, 11/15/10 - 10:51 am
Eli Lilly
financing
Cerulean
Series C
lung cancer